|
|
Volumn 46, Issue 12, 2010, Pages 2145-2149
|
|
High-dose methylprednisolone can induce remissions in patients with fludarabine-refractory chronic lymphocytic leukaemia
a
a
a
a
a
a
a
a
a
|
|
Author keywords
Chronic lymphocytic leukaemia; Methylprednisolone; Salvage therapy
|
|
Indexed keywords
CD38 ANTIGEN;
FLUDARABINE;
IMMUNOGLOBULIN HEAVY CHAIN;
METHYLPREDNISOLONE;
PROTEIN KINASE ZAP 70;
PROTEIN P53;
ADULT;
AGED;
ANEMIA;
ARTICLE;
CANCER SURVIVAL;
CHRONIC LYMPHATIC LEUKEMIA;
CLINICAL ARTICLE;
CLINICAL EVALUATION;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
FEMALE;
FLUID RETENTION;
FOLLOW UP;
HUMAN;
HYPERACTIVITY;
HYPERGLYCEMIA;
INSOMNIA;
LEUKEMIA CELL;
MALE;
MULTIPLE CYCLE TREATMENT;
NEUTROPENIA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
PROTEIN EXPRESSION;
REMISSION;
SIDE EFFECT;
THROMBOCYTOPENIA;
TREATMENT DURATION;
TREATMENT RESPONSE;
AGED;
ANTINEOPLASTIC AGENTS;
DISEASE PROGRESSION;
DRUG RESISTANCE, NEOPLASM;
FEMALE;
HUMANS;
INFUSIONS, INTRAVENOUS;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
REMISSION INDUCTION;
TREATMENT OUTCOME;
VIDARABINE;
|
|
EID: 77955713977
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/j.ejca.2010.04.021 Document Type: Article |
|
Times cited : (8)
|
|
References (6)
|
